Patient-Reported Outcomes in PHiladelphia-nEgative Cytogenetic mYeloproliferative Neoplasms (PROPHECY).
Clinical trial NCT04378855 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04378855
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-05-29
- Primary completion
- 2023-11-15
- Enrollment
- 572
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.